Relation of hemochromatosis with hepatocellular carcinoma: epidemiology, natural history, pathophysiology, screening, treatment, and prevention.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  The Medical clinics of North America

• Publication date

  2005-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.MCNA.2004.08.005PMID 15656932
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intestinal absorption of iron in HFE-1 hemochromatosis: local or systemic process?

  2004cited by this paper
• Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives.

  2003cited by this paper
• Hereditary hemochromatosis: update for 2003.

  2003cited by this paper
• Treatment of hepatocellular carcinoma.

  2003cited by this paper
• Iron uptake from plasma transferrin by the duodenum is impaired in the Hfe knockout mouse

  2002cited by this paper
• Mechanisms of iron accumulation in hereditary hemochromatosis.

  2002cited by this paper
• Screening for hemochromatosis.

  2002cited by this paper
• Molecular Targets for Prevention of Hepatocellular Carcinoma

  2002cited by this paper
• Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA

  2002cited by this paper
• Regulation of transferrin-mediated iron uptake by HFE, the protein defective in hereditary hemochromatosis

  2002cited by this paper
• Should we screen for hemochromatosis? An examination of evidence of downstream effects on morbidity and mortality.

  2002cited by this paper
• Accelerated hepatic fibrosis in patients with combined hereditary hemochromatosis and chronic hepatitis C infection.

  2002cited by this paper
• Prevalence and penetrance of HFE mutations in 4865 unselected primary care patients.

  2002cited by this paper
• Management of Nonalcoholic Steatohepatitis: An Analytic Review

  2002cited by this paper
• Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial.

  2002cited by this paper
• A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation.

  2002cited by this paper
• Intestinal expression of genes involved in iron absorption in humans.

  2002cited by this paper
• Pathogenesis of hereditary hemochromatosis: genetics and beyond.

  2002cited by this paper
• Inactivation of the hemochromatosis gene differentially regulates duodenal expression of iron-related mRNAs between mouse strains.

  2002cited by this paper
• Molecular pathogenesis of iron overload

  2002cited by this paper
• Hepatocellular Carcinoma: Systemic Treatments

  2002cited by this paper
• Population screening for hemochromatosis--are we finding people with a disease or a biochemical curiosity?

  2002cited by this paper
• Hemochromatosis and porphyria.

  2002cited by this paper
• Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis.

  2002cited by this paper
• Risk of primary non-hepatocellular malignancies in hereditary hemochromatosis.

  2002cited by this paper
• Underdiagnosis of hereditary haemochromatosis: lack of presentation or penetration?

  2002cited by this paper
• Iron in hepatitis C: villain or innocent bystander?

  2002cited by this paper
• Hepatocellular carcinoma: current surgical management.

  2001cited by this paper
• Pumping iron: the strange partnership of the hemochromatosis protein, a class I MHC homolog, with the transferrin receptor

  2001cited by this paper
• Intestinal iron uptake determined by divalent metal transporter is enhanced in HFE-deficient mice with hemochromatosis.

  2001cited by this paper
• Molecular aspects of iron absorption and HFE expression.

  2001cited by this paper
• Iron and hepatocellular carcinoma

  2001cited by this paper
• Imaging of hepatocellular carcinoma: a practical approach.

  2001cited by this paper
• Hemochromatosis: diagnosis and management.

  2001cited by this paper
• Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non–iron‐related chronic liver disease

  2001cited by this paper
• Expression of the duodenal iron transporters divalent-metal transporter 1 and ferroportin 1 in iron deficiency and iron overload.

  2001cited by this paper
• An Iron-Regulated Ferric Reductase Associated with the Absorption of Dietary Iron

  2001cited by this paper
• HFE Genotype in Patients with Hemochromatosis and Other Liver Diseases

  2000cited by this paper
• Clinical significance of hepatic resection in hepatocellular carcinoma: analysis by disease-free survival curves.

  2000cited by this paper
• Interaction between Haemochromatosis and Transferrin Receptor Genes in Hepatocellular Carcinoma

  2000cited by this paper
• Natural history of inoperable hepatocellular carcinoma: Estrogen receptors' status in the tumor is the strongest prognostic factor for survival

  2000cited by this paper
• Nonexpressing homozygotes for C282Y hemochromatosis: minority or majority of cases?

  2000cited by this paper
• Screening for Hereditary Hemochromatosis in Siblings and Children of Affected Patients: A Cost-Effectiveness Analysis

  2000cited by this paper
• Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter

  2000cited by this paper
• A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation.

  2000cited by this paper
• Haemochromatosis in the new millennium.

  2000cited by this paper
• Results of surgical and nonsurgical treatment for small‐sized hepatocellular carcinomas: A retrospective and nationwide survey in Japan

  2000cited by this paper
• Hepatocellular Carcinoma Arising in Non-Cirrhotic Liver in Genetic Haemochromatosis

  2000cited by this paper
• EASL International Consensus Conference on Haemochromatosis.

  2000cited by this paper
• Can large cell change and high proliferative activity predict hepatocellular carcinoma in patients with hereditary hemochromatosis?

  2000cited by this paper
• Can large cell change and high proliferative activity predict hepatocellular carcinoma in patients with hereditary hemochromatosis

  2000cited by this paper
• Hepatocellular carcinoma occurring in nonfibrotic liver: Epidemiologic and histopathologic analysis of 80 French cases

  2000cited by this paper
• Mechanism of increased iron absorption in murine model of hereditary hemochromatosis: increased duodenal expression of the iron transporter DMT1.

  1999cited by this paper
• Duodenal metal-transporter (DMT-1, NRAMP-2) expression in patients with hereditary haemochromatosis.

  1999cited by this paper
• Iron regulatory protein as an endogenous sensor of iron in rat intestinal mucosa. Possible implications for the regulation of iron absorption.

  1999cited by this paper
• Magnetic resonance iron-free nodules in genetic hemochromatosis

  1999cited by this paper
• Regulatory peptide receptors in human hepatocellular carcinomas

  1999cited by this paper
• Disorders of iron metabolism.

  1999cited by this paper
• Association of HFE protein with transferrin receptor in crypt enterocytes of human duodenum.

  1999cited by this paper
• Molecular medicine and hemochromatosis: at the crossroads.

  1999cited by this paper
• Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse

  1999cited by this paper
• A population-based study of the clinical expression of the hemochromatosis gene.

  1999cited by this paper
• Hepatocellular carcinoma in a patient with hereditary hemochromatosis and noncirrhotic liver. A case report.

  1999cited by this paper
• Hepatocellular carcinoma arising in the absence of cirrhosis in genetic haemochromatosis: three case reports and review of literature.

  1999cited by this paper
• p53 mutations in british patients with hepatocellular carcinoma: clustering in genetic hemochromatosis.

  1999cited by this paper
• The significance of haemochromatosis gene mutations in the general population: implications for screening.

  1998cited by this paper
• The significance of haemochromatosis gene mutations in the general population: implications for screening

  1998cited by this paper
• Onset of hepatocellular carcinoma in a non-cirrhotic patient affected with haemochromatosis.

  1998cited by this paper
• Tamoxifen does not improve survival of patients with advanced hepatocellular carcinoma.

  1998cited by this paper
• Induction of microsatellite instability by oxidative DNA damage.

  1998cited by this paper
• Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study

  1998cited by this paper
• Early Diagnosis of Hepatocellular Carcinoma in Haemochromatosis Influences Surgical Management

  1998cited by this paper
• Dietary iron overload as a risk factor for hepatocellular carcinoma in black africans

  1998cited by this paper
• Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor.

  1998cited by this paper
• Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis.

  1998cited by this paper
• Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene

  1997cited by this paper
• Cloning and characterization of a mammalian proton-coupled metal-ion transporter

  1997cited by this paper
• Mutation analysis of the HLA-H gene in Italian hemochromatosis patients.

  1997cited by this paper
• A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis

  1996cited by this paper
• Hemochromatosis: the impact of early diagnosis and therapy.

  1996cited by this paper
• Small hepatocellular carcinoma in patients with chronic liver damage: prospective comparison of detection with dynamic MR imaging and helical CT of the whole liver.

  1996cited by this paper
• Hepatocellular carcinoma: evaluation with biphasic, contrast-enhanced, helical CT.

  1996cited by this paper
• Long-term survival in patients with hereditary hemochromatosis.

  1996cited by this paper
• Tissue‐specific growth suppression and chemosensitivity promotion in human hepatocellular carcinoma cells by retroviral‐mediated transfer of the wild‐type p53 gene

  1996cited by this paper
• Risk of neoplastic and other diseases among people with heterozygosity for hereditary hemochromatosis

  1995cited by this paper
• Cancer risk following primary hemochromatosis: A population‐based cohort study in Denmark

  1995cited by this paper
• Liver transplantation for hemochromatosis: an ironic dilemma.

  1995cited by this paper
• Iron as a hepatotoxin.

  1995cited by this paper
• Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: Incidence and prevalence of hepatocellular carcinoma in a North American urban population

  1995cited by this paper
• Primary liver cancer and survival in patients undergoing liver transplantation for hemochromatosis.

  1995cited by this paper
• Nonalcoholic steatohepatitis: an expanded clinical entity.

  1994cited by this paper
• Prognostic factors for hepatocellular carcinoma in genetic hemochromatosis

  1994cited by this paper
• Outcome of liver transplantation in patients with hemochromatosis

  1994cited by this paper
• Prospective study of α‐fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma

  1994cited by this paper
• Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma.

  1994cited by this paper
• Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis.

  1994cited by this paper
• Malignancies in patients with cirrhosis: CT sensitivity and specificity in 200 consecutive transplant patients.

  1994cited by this paper
• Neuroblastoma sensitivity to growth inhibition by deferrioxamine: evidence for a block in G1 phase of the cell cycle.

  1993cited by this paper
• Primary liver cancer in genetic hemochromatosis: a clinical, pathological, and pathogenetic study of 54 cases.

  1993cited by this paper
• Preneoplastic significance of hepatic iron–free foci in genetic hemochromatosis: A study of 185 patients

  1993cited by this paper

• Nanozyme for precision treatment of hepatocellular carcinoma

  2026cites this paper
• Hereditary hemochromatosis: pathogenesis, symptoms, diagnosis and current treatment - literature review

  2025cites this paper
• Hepatic Iron Overload and Hepatocellular Carcinoma: New Insights into Pathophysiological Mechanisms and Therapeutic Approaches

  2025cites this paper
• Clinical Spectrum of Cirrhosis of Liver-a Study of 100 Cases

  2025cites this paper
• Using Dual-source Photon-counting Detector CT to Simultaneously Quantify Fat and Iron Content: A Phantom Study.

  2024cites this paper
• Role of Iron in Aging Related Diseases

  2022cites this paper
• Letter to the editor: Hepatitis B virus genotype: A significant risk factor in determining which patients with chronic hepatitis B virus infection should undergo surveillance for hepatocellular carcinoma: The hepatitis B Alaska study

  2022cites this paper
• Epidemiology, mutational landscape and staging of hepatocellular carcinoma.

  2021cites this paper
• Simultaneous hepatic iron and fat quantification with dual-energy CT in a rabbit model of coexisting iron and fat.

  2021cites this paper
• Association between hereditary hemochromatosis and hepatocellular carcinoma: a comprehensive review

  2020cites this paper
• RETROSPECTIVE EVALUATION OF HEPATOCELLULAR NEOPLASMS IN NILE LECHWE (KOBUS MEGACEROS) FROM TWO FLORIDA ZOOLOGICAL INSTITUTIONS

  2020cites this paper
• Study of the role of the adaptor protein MyD88 in the iron-sensing pathway and of the effect of curcumin in the development of anemia in a DSS-induced colitis mouse model

  2019cites this paper
• Overview of Virus Infection and Tumorigenesis

  2019cites this paper
• Serum Biomarkers of Iron Status and Risk of Primary Liver Cancer: A Systematic Review and Meta-Analysis

  2019cites this paper
• Dietary and Sentinel Factors Leading to Hemochromatosis

  2019cites this paper
• Quantitative susceptibility mapping in combination with water-fat separation for simultaneous liver iron and fat fraction quantification

  2018cites this paper
• Generic chemoprevention of hepatocellular carcinoma

  2018cites this paper
• Magnetic resonance assessment of myocardial and hepatic iron overload : Beyond invasive technics.

  2018cites this paper
• 4 – Disorders of Iron Overload

  2018cites this paper
• LIVER CANCER IN THE WORLD: EPIDEMIOLOGY, INCIDENCE, MORTALITY AND RISK FACTORS

  2018cites this paper
• Juvenile hemochromatosis and hepatocellular carcinoma in a patient with a novel mutation in the HJV gene.

  2017cites this paper
• Epidemiology of Hepatocellular Carcinoma

  2017cites this paper
• Serum Golgi protein-73 in combination with α-fetoprotein for diagnosing hepatocellular carcinoma in Egyptian patients

  2017cites this paper
• Assessment of liver iron overload by 3 T MRI

  2017cites this paper
• Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

  2017influential citation
• Hemochromatosis, Wilson's Disease, and Alpha‐1‐Antitrypsin Deficiency

  2016cites this paper
• Chemoembolization With Drug-Eluting Beads for the Treatment of Hepatocellular Carcinoma

  2016cites this paper
• A RETROSPECTIVE STUDY OF THE LESIONS ASSOCIATED WITH IRON STORAGE DISEASE IN CAPTIVE EGYPTIAN FRUIT BATS (ROUSETTUS AEGYPTIACUS)

  2016cites this paper
• Etiology and Pathogenesis of Hepatocellular Carcinoma: Hepatocellular Carcinoma Associated with Inborn Errors of Metabolism and Hepatobiliary Malformations

  2016cites this paper
• Chapter 41 – Iron

  2015cites this paper
• DIAGNOSTIC METHODS FOR NON-ALCOHOLIC FATTY LIVER DISEASES ALTERNATIVE TO LIVER BIOPSY: A REVIEW

  2015cites this paper
• HFE Genotyping in Patients with Elevated Serum Iron Indices and Liver Diseases

  2015cites this paper
• Metabolic dysregulation in monogenic disorders and cancer — finding method in madness

  2015cites this paper
• Hepatocellular carcinoma epidemiology.

  2014cites this paper
• Hereditary hemochromatosis.

  2013cites this paper
• The Impact of Treating Chronic Liver Diseases on Hepatocellular Carcinoma Prevention

  2012cites this paper
• Hepatic Pathobiology of Iron Overload

  2012cites this paper
• 5 – Disorders of iron overload

  2012cites this paper
• [From iron accumulation to organ damage].

  2012cites this paper
• Hepatocellular Carcinoma: Prevention and Therapy

  2011cites this paper
• Insights into the pathogenesis and treatment of cancer from inborn errors of metabolism.

  2011cites this paper
• Mechanisms of Liver Injury

  2011cites this paper
• Therapeutic phlebotomy procedures and their impact on a rural hospital's red blood cell inventory and fiscal stature

  2011cites this paper
• Hemochromatosis and Iron Storage Disorders

  2011cites this paper
• Magnetic resonance imaging quantification of liver iron.

  2010cites this paper
• Inherited hepatocellular carcinoma.

  2010cites this paper
• Evaluation of Possible Carcinogenic Risk to Humans Based on Liver Tumors in Rodent Assays

  2010cites this paper
• A Propósito de um Caso de Cirrose Hepática.

  2010cites this paper
• Abnormal iron uptake and liver cancer

  2009cites this paper
• Advanced MRI methods for assessment of chronic liver disease.

  2009influential citation
• HFE-associated hereditary hemochromatosis

  2009cites this paper
• Cáncer experimental e inflamación sistémica en un modelo murino

  2007cites this paper
• CHAPTER 30 – Iron

  2007cites this paper
• [Systemic inflammation and experimental cancer in a murine model].

  2007cites this paper
• Allogeneic Transplantation and the Risk for Transmission of Genetic Disease: The Heritable Cancer Disorders

  2007cites this paper
• Interaction between dietary iron overload and aflatoxin B1 in hepatocarcinogenesis using an experimental rat model

  2007cites this paper
• Cirrhosis and chronic liver failure: part I. Diagnosis and evaluation.

  2006cites this paper
• Mode of action in relevance of rodent liver tumors to human cancer risk.

  2006cites this paper
• Surgery for Hepatocellular Carcinoma Arising in Hereditary Hemochromatosis

  2006cites this paper
• General assessment of the patient with cancer for the interventional oncologist.

  2006cites this paper
• Mutations of the HFE gene among Turkish hereditary hemochromatosis patients

  2005cites this paper
• Theoretical Biology and Medical Modelling Open Access the Biological Sense of Cancer: a Hypothesis

  year unknowncites this paper